Review of the evidence on the use of electrical muscle stimulation to treat sarcopenia
Electrical muscle stimulation (EMS) has been shown to increase muscle strength and mass, suggesting that it can be used for the treatment of sarcopenia. We herein present a detailed review of the physiological changes induced by EMS. Only human experimental and clinical studies were selected as refe...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Nishida, M.M. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2016transfer abstract |
|---|
| Schlagwörter: |
|---|
| Umfang: |
5 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Effects of the nitrification inhibitor nitrapyrin and mulch on N - Dawar, Khadim ELSEVIER, 2020, EGM, [Cham] |
|---|---|
| Übergeordnetes Werk: |
volume:7 ; year:2016 ; number:3 ; pages:267-271 ; extent:5 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.eurger.2015.11.010 |
|---|
| Katalog-ID: |
ELV019384955 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV019384955 | ||
| 003 | DE-627 | ||
| 005 | 20230625125846.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.eurger.2015.11.010 |2 doi | |
| 028 | 5 | 2 | |a GBVA2016011000015.pica |
| 035 | |a (DE-627)ELV019384955 | ||
| 035 | |a (ELSEVIER)S1878-7649(15)00232-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 333.7 |a 610 |q VZ |
| 084 | |a 43.12 |2 bkl | ||
| 084 | |a 43.13 |2 bkl | ||
| 084 | |a 44.13 |2 bkl | ||
| 100 | 1 | |a Nishida, M.M. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Review of the evidence on the use of electrical muscle stimulation to treat sarcopenia |
| 264 | 1 | |c 2016transfer abstract | |
| 300 | |a 5 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Electrical muscle stimulation (EMS) has been shown to increase muscle strength and mass, suggesting that it can be used for the treatment of sarcopenia. We herein present a detailed review of the physiological changes induced by EMS. Only human experimental and clinical studies were selected as reference articles for this review. Low-frequency stimulation appears to have greater effects on strengthening, while high frequency favors an increase in muscle mass. EMS also promotes compositional changes of the muscle fibers and improvements in the oxidative enzymatic activity and glucose uptake. Considering that structural changes towards type II muscle fibers and their motor units have an important role in the loss of muscle strength and that the response to muscular training is based on the capacity to increase muscle activation, an intervention protocol using EMS should focus on stimulating type II muscle fibers, rather than on inducing muscle hypertrophy. | ||
| 520 | |a Electrical muscle stimulation (EMS) has been shown to increase muscle strength and mass, suggesting that it can be used for the treatment of sarcopenia. We herein present a detailed review of the physiological changes induced by EMS. Only human experimental and clinical studies were selected as reference articles for this review. Low-frequency stimulation appears to have greater effects on strengthening, while high frequency favors an increase in muscle mass. EMS also promotes compositional changes of the muscle fibers and improvements in the oxidative enzymatic activity and glucose uptake. Considering that structural changes towards type II muscle fibers and their motor units have an important role in the loss of muscle strength and that the response to muscular training is based on the capacity to increase muscle activation, an intervention protocol using EMS should focus on stimulating type II muscle fibers, rather than on inducing muscle hypertrophy. | ||
| 650 | 7 | |a Dynapenia |2 Elsevier | |
| 650 | 7 | |a Sarcopenia |2 Elsevier | |
| 650 | 7 | |a Electrical muscle stimulation |2 Elsevier | |
| 700 | 1 | |a Tsuboyama, T. |4 oth | |
| 700 | 1 | |a Moritani, T. |4 oth | |
| 700 | 1 | |a Arai, H. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Springer International Publishing |a Dawar, Khadim ELSEVIER |t Effects of the nitrification inhibitor nitrapyrin and mulch on N |d 2020 |d EGM |g [Cham] |w (DE-627)ELV005292379 |
| 773 | 1 | 8 | |g volume:7 |g year:2016 |g number:3 |g pages:267-271 |g extent:5 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.eurger.2015.11.010 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-GGO | ||
| 936 | b | k | |a 43.12 |j Umweltchemie |q VZ |
| 936 | b | k | |a 43.13 |j Umwelttoxikologie |q VZ |
| 936 | b | k | |a 44.13 |j Medizinische Ökologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 7 |j 2016 |e 3 |h 267-271 |g 5 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
m n mn |
|---|---|
| matchkey_str |
nishidammtsuboyamatmoritanitaraih:2016----:eiwfheiecotesoeetiamslsiuai |
| hierarchy_sort_str |
2016transfer abstract |
| bklnumber |
43.12 43.13 44.13 |
| publishDate |
2016 |
| allfields |
10.1016/j.eurger.2015.11.010 doi GBVA2016011000015.pica (DE-627)ELV019384955 (ELSEVIER)S1878-7649(15)00232-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Nishida, M.M. verfasserin aut Review of the evidence on the use of electrical muscle stimulation to treat sarcopenia 2016transfer abstract 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Electrical muscle stimulation (EMS) has been shown to increase muscle strength and mass, suggesting that it can be used for the treatment of sarcopenia. We herein present a detailed review of the physiological changes induced by EMS. Only human experimental and clinical studies were selected as reference articles for this review. Low-frequency stimulation appears to have greater effects on strengthening, while high frequency favors an increase in muscle mass. EMS also promotes compositional changes of the muscle fibers and improvements in the oxidative enzymatic activity and glucose uptake. Considering that structural changes towards type II muscle fibers and their motor units have an important role in the loss of muscle strength and that the response to muscular training is based on the capacity to increase muscle activation, an intervention protocol using EMS should focus on stimulating type II muscle fibers, rather than on inducing muscle hypertrophy. Electrical muscle stimulation (EMS) has been shown to increase muscle strength and mass, suggesting that it can be used for the treatment of sarcopenia. We herein present a detailed review of the physiological changes induced by EMS. Only human experimental and clinical studies were selected as reference articles for this review. Low-frequency stimulation appears to have greater effects on strengthening, while high frequency favors an increase in muscle mass. EMS also promotes compositional changes of the muscle fibers and improvements in the oxidative enzymatic activity and glucose uptake. Considering that structural changes towards type II muscle fibers and their motor units have an important role in the loss of muscle strength and that the response to muscular training is based on the capacity to increase muscle activation, an intervention protocol using EMS should focus on stimulating type II muscle fibers, rather than on inducing muscle hypertrophy. Dynapenia Elsevier Sarcopenia Elsevier Electrical muscle stimulation Elsevier Tsuboyama, T. oth Moritani, T. oth Arai, H. oth Enthalten in Springer International Publishing Dawar, Khadim ELSEVIER Effects of the nitrification inhibitor nitrapyrin and mulch on N 2020 EGM [Cham] (DE-627)ELV005292379 volume:7 year:2016 number:3 pages:267-271 extent:5 https://doi.org/10.1016/j.eurger.2015.11.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 7 2016 3 267-271 5 045F 610 |
| spelling |
10.1016/j.eurger.2015.11.010 doi GBVA2016011000015.pica (DE-627)ELV019384955 (ELSEVIER)S1878-7649(15)00232-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Nishida, M.M. verfasserin aut Review of the evidence on the use of electrical muscle stimulation to treat sarcopenia 2016transfer abstract 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Electrical muscle stimulation (EMS) has been shown to increase muscle strength and mass, suggesting that it can be used for the treatment of sarcopenia. We herein present a detailed review of the physiological changes induced by EMS. Only human experimental and clinical studies were selected as reference articles for this review. Low-frequency stimulation appears to have greater effects on strengthening, while high frequency favors an increase in muscle mass. EMS also promotes compositional changes of the muscle fibers and improvements in the oxidative enzymatic activity and glucose uptake. Considering that structural changes towards type II muscle fibers and their motor units have an important role in the loss of muscle strength and that the response to muscular training is based on the capacity to increase muscle activation, an intervention protocol using EMS should focus on stimulating type II muscle fibers, rather than on inducing muscle hypertrophy. Electrical muscle stimulation (EMS) has been shown to increase muscle strength and mass, suggesting that it can be used for the treatment of sarcopenia. We herein present a detailed review of the physiological changes induced by EMS. Only human experimental and clinical studies were selected as reference articles for this review. Low-frequency stimulation appears to have greater effects on strengthening, while high frequency favors an increase in muscle mass. EMS also promotes compositional changes of the muscle fibers and improvements in the oxidative enzymatic activity and glucose uptake. Considering that structural changes towards type II muscle fibers and their motor units have an important role in the loss of muscle strength and that the response to muscular training is based on the capacity to increase muscle activation, an intervention protocol using EMS should focus on stimulating type II muscle fibers, rather than on inducing muscle hypertrophy. Dynapenia Elsevier Sarcopenia Elsevier Electrical muscle stimulation Elsevier Tsuboyama, T. oth Moritani, T. oth Arai, H. oth Enthalten in Springer International Publishing Dawar, Khadim ELSEVIER Effects of the nitrification inhibitor nitrapyrin and mulch on N 2020 EGM [Cham] (DE-627)ELV005292379 volume:7 year:2016 number:3 pages:267-271 extent:5 https://doi.org/10.1016/j.eurger.2015.11.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 7 2016 3 267-271 5 045F 610 |
| allfields_unstemmed |
10.1016/j.eurger.2015.11.010 doi GBVA2016011000015.pica (DE-627)ELV019384955 (ELSEVIER)S1878-7649(15)00232-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Nishida, M.M. verfasserin aut Review of the evidence on the use of electrical muscle stimulation to treat sarcopenia 2016transfer abstract 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Electrical muscle stimulation (EMS) has been shown to increase muscle strength and mass, suggesting that it can be used for the treatment of sarcopenia. We herein present a detailed review of the physiological changes induced by EMS. Only human experimental and clinical studies were selected as reference articles for this review. Low-frequency stimulation appears to have greater effects on strengthening, while high frequency favors an increase in muscle mass. EMS also promotes compositional changes of the muscle fibers and improvements in the oxidative enzymatic activity and glucose uptake. Considering that structural changes towards type II muscle fibers and their motor units have an important role in the loss of muscle strength and that the response to muscular training is based on the capacity to increase muscle activation, an intervention protocol using EMS should focus on stimulating type II muscle fibers, rather than on inducing muscle hypertrophy. Electrical muscle stimulation (EMS) has been shown to increase muscle strength and mass, suggesting that it can be used for the treatment of sarcopenia. We herein present a detailed review of the physiological changes induced by EMS. Only human experimental and clinical studies were selected as reference articles for this review. Low-frequency stimulation appears to have greater effects on strengthening, while high frequency favors an increase in muscle mass. EMS also promotes compositional changes of the muscle fibers and improvements in the oxidative enzymatic activity and glucose uptake. Considering that structural changes towards type II muscle fibers and their motor units have an important role in the loss of muscle strength and that the response to muscular training is based on the capacity to increase muscle activation, an intervention protocol using EMS should focus on stimulating type II muscle fibers, rather than on inducing muscle hypertrophy. Dynapenia Elsevier Sarcopenia Elsevier Electrical muscle stimulation Elsevier Tsuboyama, T. oth Moritani, T. oth Arai, H. oth Enthalten in Springer International Publishing Dawar, Khadim ELSEVIER Effects of the nitrification inhibitor nitrapyrin and mulch on N 2020 EGM [Cham] (DE-627)ELV005292379 volume:7 year:2016 number:3 pages:267-271 extent:5 https://doi.org/10.1016/j.eurger.2015.11.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 7 2016 3 267-271 5 045F 610 |
| allfieldsGer |
10.1016/j.eurger.2015.11.010 doi GBVA2016011000015.pica (DE-627)ELV019384955 (ELSEVIER)S1878-7649(15)00232-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Nishida, M.M. verfasserin aut Review of the evidence on the use of electrical muscle stimulation to treat sarcopenia 2016transfer abstract 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Electrical muscle stimulation (EMS) has been shown to increase muscle strength and mass, suggesting that it can be used for the treatment of sarcopenia. We herein present a detailed review of the physiological changes induced by EMS. Only human experimental and clinical studies were selected as reference articles for this review. Low-frequency stimulation appears to have greater effects on strengthening, while high frequency favors an increase in muscle mass. EMS also promotes compositional changes of the muscle fibers and improvements in the oxidative enzymatic activity and glucose uptake. Considering that structural changes towards type II muscle fibers and their motor units have an important role in the loss of muscle strength and that the response to muscular training is based on the capacity to increase muscle activation, an intervention protocol using EMS should focus on stimulating type II muscle fibers, rather than on inducing muscle hypertrophy. Electrical muscle stimulation (EMS) has been shown to increase muscle strength and mass, suggesting that it can be used for the treatment of sarcopenia. We herein present a detailed review of the physiological changes induced by EMS. Only human experimental and clinical studies were selected as reference articles for this review. Low-frequency stimulation appears to have greater effects on strengthening, while high frequency favors an increase in muscle mass. EMS also promotes compositional changes of the muscle fibers and improvements in the oxidative enzymatic activity and glucose uptake. Considering that structural changes towards type II muscle fibers and their motor units have an important role in the loss of muscle strength and that the response to muscular training is based on the capacity to increase muscle activation, an intervention protocol using EMS should focus on stimulating type II muscle fibers, rather than on inducing muscle hypertrophy. Dynapenia Elsevier Sarcopenia Elsevier Electrical muscle stimulation Elsevier Tsuboyama, T. oth Moritani, T. oth Arai, H. oth Enthalten in Springer International Publishing Dawar, Khadim ELSEVIER Effects of the nitrification inhibitor nitrapyrin and mulch on N 2020 EGM [Cham] (DE-627)ELV005292379 volume:7 year:2016 number:3 pages:267-271 extent:5 https://doi.org/10.1016/j.eurger.2015.11.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 7 2016 3 267-271 5 045F 610 |
| allfieldsSound |
10.1016/j.eurger.2015.11.010 doi GBVA2016011000015.pica (DE-627)ELV019384955 (ELSEVIER)S1878-7649(15)00232-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Nishida, M.M. verfasserin aut Review of the evidence on the use of electrical muscle stimulation to treat sarcopenia 2016transfer abstract 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Electrical muscle stimulation (EMS) has been shown to increase muscle strength and mass, suggesting that it can be used for the treatment of sarcopenia. We herein present a detailed review of the physiological changes induced by EMS. Only human experimental and clinical studies were selected as reference articles for this review. Low-frequency stimulation appears to have greater effects on strengthening, while high frequency favors an increase in muscle mass. EMS also promotes compositional changes of the muscle fibers and improvements in the oxidative enzymatic activity and glucose uptake. Considering that structural changes towards type II muscle fibers and their motor units have an important role in the loss of muscle strength and that the response to muscular training is based on the capacity to increase muscle activation, an intervention protocol using EMS should focus on stimulating type II muscle fibers, rather than on inducing muscle hypertrophy. Electrical muscle stimulation (EMS) has been shown to increase muscle strength and mass, suggesting that it can be used for the treatment of sarcopenia. We herein present a detailed review of the physiological changes induced by EMS. Only human experimental and clinical studies were selected as reference articles for this review. Low-frequency stimulation appears to have greater effects on strengthening, while high frequency favors an increase in muscle mass. EMS also promotes compositional changes of the muscle fibers and improvements in the oxidative enzymatic activity and glucose uptake. Considering that structural changes towards type II muscle fibers and their motor units have an important role in the loss of muscle strength and that the response to muscular training is based on the capacity to increase muscle activation, an intervention protocol using EMS should focus on stimulating type II muscle fibers, rather than on inducing muscle hypertrophy. Dynapenia Elsevier Sarcopenia Elsevier Electrical muscle stimulation Elsevier Tsuboyama, T. oth Moritani, T. oth Arai, H. oth Enthalten in Springer International Publishing Dawar, Khadim ELSEVIER Effects of the nitrification inhibitor nitrapyrin and mulch on N 2020 EGM [Cham] (DE-627)ELV005292379 volume:7 year:2016 number:3 pages:267-271 extent:5 https://doi.org/10.1016/j.eurger.2015.11.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 7 2016 3 267-271 5 045F 610 |
| language |
English |
| source |
Enthalten in Effects of the nitrification inhibitor nitrapyrin and mulch on N [Cham] volume:7 year:2016 number:3 pages:267-271 extent:5 |
| sourceStr |
Enthalten in Effects of the nitrification inhibitor nitrapyrin and mulch on N [Cham] volume:7 year:2016 number:3 pages:267-271 extent:5 |
| format_phy_str_mv |
Article |
| bklname |
Umweltchemie Umwelttoxikologie Medizinische Ökologie |
| institution |
findex.gbv.de |
| topic_facet |
Dynapenia Sarcopenia Electrical muscle stimulation |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Effects of the nitrification inhibitor nitrapyrin and mulch on N |
| authorswithroles_txt_mv |
Nishida, M.M. @@aut@@ Tsuboyama, T. @@oth@@ Moritani, T. @@oth@@ Arai, H. @@oth@@ |
| publishDateDaySort_date |
2016-01-01T00:00:00Z |
| hierarchy_top_id |
ELV005292379 |
| dewey-sort |
3610 |
| id |
ELV019384955 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV019384955</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625125846.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.eurger.2015.11.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016011000015.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV019384955</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1878-7649(15)00232-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">333.7</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Nishida, M.M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Review of the evidence on the use of electrical muscle stimulation to treat sarcopenia</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Electrical muscle stimulation (EMS) has been shown to increase muscle strength and mass, suggesting that it can be used for the treatment of sarcopenia. We herein present a detailed review of the physiological changes induced by EMS. Only human experimental and clinical studies were selected as reference articles for this review. Low-frequency stimulation appears to have greater effects on strengthening, while high frequency favors an increase in muscle mass. EMS also promotes compositional changes of the muscle fibers and improvements in the oxidative enzymatic activity and glucose uptake. Considering that structural changes towards type II muscle fibers and their motor units have an important role in the loss of muscle strength and that the response to muscular training is based on the capacity to increase muscle activation, an intervention protocol using EMS should focus on stimulating type II muscle fibers, rather than on inducing muscle hypertrophy.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Electrical muscle stimulation (EMS) has been shown to increase muscle strength and mass, suggesting that it can be used for the treatment of sarcopenia. We herein present a detailed review of the physiological changes induced by EMS. Only human experimental and clinical studies were selected as reference articles for this review. Low-frequency stimulation appears to have greater effects on strengthening, while high frequency favors an increase in muscle mass. EMS also promotes compositional changes of the muscle fibers and improvements in the oxidative enzymatic activity and glucose uptake. Considering that structural changes towards type II muscle fibers and their motor units have an important role in the loss of muscle strength and that the response to muscular training is based on the capacity to increase muscle activation, an intervention protocol using EMS should focus on stimulating type II muscle fibers, rather than on inducing muscle hypertrophy.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Dynapenia</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Sarcopenia</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Electrical muscle stimulation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tsuboyama, T.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Moritani, T.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Arai, H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Springer International Publishing</subfield><subfield code="a">Dawar, Khadim ELSEVIER</subfield><subfield code="t">Effects of the nitrification inhibitor nitrapyrin and mulch on N</subfield><subfield code="d">2020</subfield><subfield code="d">EGM</subfield><subfield code="g">[Cham]</subfield><subfield code="w">(DE-627)ELV005292379</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:7</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:267-271</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.eurger.2015.11.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GGO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.12</subfield><subfield code="j">Umweltchemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.13</subfield><subfield code="j">Umwelttoxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.13</subfield><subfield code="j">Medizinische Ökologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">7</subfield><subfield code="j">2016</subfield><subfield code="e">3</subfield><subfield code="h">267-271</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Nishida, M.M. |
| spellingShingle |
Nishida, M.M. ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13 Elsevier Dynapenia Elsevier Sarcopenia Elsevier Electrical muscle stimulation Review of the evidence on the use of electrical muscle stimulation to treat sarcopenia |
| authorStr |
Nishida, M.M. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV005292379 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 333 - Economics of land & energy |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Review of the evidence on the use of electrical muscle stimulation to treat sarcopenia Dynapenia Elsevier Sarcopenia Elsevier Electrical muscle stimulation Elsevier |
| topic |
ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13 Elsevier Dynapenia Elsevier Sarcopenia Elsevier Electrical muscle stimulation |
| topic_unstemmed |
ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13 Elsevier Dynapenia Elsevier Sarcopenia Elsevier Electrical muscle stimulation |
| topic_browse |
ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13 Elsevier Dynapenia Elsevier Sarcopenia Elsevier Electrical muscle stimulation |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
t t tt t m tm h a ha |
| hierarchy_parent_title |
Effects of the nitrification inhibitor nitrapyrin and mulch on N |
| hierarchy_parent_id |
ELV005292379 |
| dewey-tens |
610 - Medicine & health 330 - Economics |
| hierarchy_top_title |
Effects of the nitrification inhibitor nitrapyrin and mulch on N |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV005292379 |
| title |
Review of the evidence on the use of electrical muscle stimulation to treat sarcopenia |
| ctrlnum |
(DE-627)ELV019384955 (ELSEVIER)S1878-7649(15)00232-6 |
| title_full |
Review of the evidence on the use of electrical muscle stimulation to treat sarcopenia |
| author_sort |
Nishida, M.M. |
| journal |
Effects of the nitrification inhibitor nitrapyrin and mulch on N |
| journalStr |
Effects of the nitrification inhibitor nitrapyrin and mulch on N |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 300 - Social sciences |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
267 |
| author_browse |
Nishida, M.M. |
| container_volume |
7 |
| physical |
5 |
| class |
610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Nishida, M.M. |
| doi_str_mv |
10.1016/j.eurger.2015.11.010 |
| dewey-full |
610 333.7 |
| title_sort |
review of the evidence on the use of electrical muscle stimulation to treat sarcopenia |
| title_auth |
Review of the evidence on the use of electrical muscle stimulation to treat sarcopenia |
| abstract |
Electrical muscle stimulation (EMS) has been shown to increase muscle strength and mass, suggesting that it can be used for the treatment of sarcopenia. We herein present a detailed review of the physiological changes induced by EMS. Only human experimental and clinical studies were selected as reference articles for this review. Low-frequency stimulation appears to have greater effects on strengthening, while high frequency favors an increase in muscle mass. EMS also promotes compositional changes of the muscle fibers and improvements in the oxidative enzymatic activity and glucose uptake. Considering that structural changes towards type II muscle fibers and their motor units have an important role in the loss of muscle strength and that the response to muscular training is based on the capacity to increase muscle activation, an intervention protocol using EMS should focus on stimulating type II muscle fibers, rather than on inducing muscle hypertrophy. |
| abstractGer |
Electrical muscle stimulation (EMS) has been shown to increase muscle strength and mass, suggesting that it can be used for the treatment of sarcopenia. We herein present a detailed review of the physiological changes induced by EMS. Only human experimental and clinical studies were selected as reference articles for this review. Low-frequency stimulation appears to have greater effects on strengthening, while high frequency favors an increase in muscle mass. EMS also promotes compositional changes of the muscle fibers and improvements in the oxidative enzymatic activity and glucose uptake. Considering that structural changes towards type II muscle fibers and their motor units have an important role in the loss of muscle strength and that the response to muscular training is based on the capacity to increase muscle activation, an intervention protocol using EMS should focus on stimulating type II muscle fibers, rather than on inducing muscle hypertrophy. |
| abstract_unstemmed |
Electrical muscle stimulation (EMS) has been shown to increase muscle strength and mass, suggesting that it can be used for the treatment of sarcopenia. We herein present a detailed review of the physiological changes induced by EMS. Only human experimental and clinical studies were selected as reference articles for this review. Low-frequency stimulation appears to have greater effects on strengthening, while high frequency favors an increase in muscle mass. EMS also promotes compositional changes of the muscle fibers and improvements in the oxidative enzymatic activity and glucose uptake. Considering that structural changes towards type II muscle fibers and their motor units have an important role in the loss of muscle strength and that the response to muscular training is based on the capacity to increase muscle activation, an intervention protocol using EMS should focus on stimulating type II muscle fibers, rather than on inducing muscle hypertrophy. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO |
| container_issue |
3 |
| title_short |
Review of the evidence on the use of electrical muscle stimulation to treat sarcopenia |
| url |
https://doi.org/10.1016/j.eurger.2015.11.010 |
| remote_bool |
true |
| author2 |
Tsuboyama, T. Moritani, T. Arai, H. |
| author2Str |
Tsuboyama, T. Moritani, T. Arai, H. |
| ppnlink |
ELV005292379 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth |
| doi_str |
10.1016/j.eurger.2015.11.010 |
| up_date |
2024-07-06T21:18:24.851Z |
| _version_ |
1803866031890890752 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV019384955</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625125846.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.eurger.2015.11.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016011000015.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV019384955</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1878-7649(15)00232-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">333.7</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Nishida, M.M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Review of the evidence on the use of electrical muscle stimulation to treat sarcopenia</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Electrical muscle stimulation (EMS) has been shown to increase muscle strength and mass, suggesting that it can be used for the treatment of sarcopenia. We herein present a detailed review of the physiological changes induced by EMS. Only human experimental and clinical studies were selected as reference articles for this review. Low-frequency stimulation appears to have greater effects on strengthening, while high frequency favors an increase in muscle mass. EMS also promotes compositional changes of the muscle fibers and improvements in the oxidative enzymatic activity and glucose uptake. Considering that structural changes towards type II muscle fibers and their motor units have an important role in the loss of muscle strength and that the response to muscular training is based on the capacity to increase muscle activation, an intervention protocol using EMS should focus on stimulating type II muscle fibers, rather than on inducing muscle hypertrophy.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Electrical muscle stimulation (EMS) has been shown to increase muscle strength and mass, suggesting that it can be used for the treatment of sarcopenia. We herein present a detailed review of the physiological changes induced by EMS. Only human experimental and clinical studies were selected as reference articles for this review. Low-frequency stimulation appears to have greater effects on strengthening, while high frequency favors an increase in muscle mass. EMS also promotes compositional changes of the muscle fibers and improvements in the oxidative enzymatic activity and glucose uptake. Considering that structural changes towards type II muscle fibers and their motor units have an important role in the loss of muscle strength and that the response to muscular training is based on the capacity to increase muscle activation, an intervention protocol using EMS should focus on stimulating type II muscle fibers, rather than on inducing muscle hypertrophy.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Dynapenia</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Sarcopenia</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Electrical muscle stimulation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tsuboyama, T.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Moritani, T.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Arai, H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Springer International Publishing</subfield><subfield code="a">Dawar, Khadim ELSEVIER</subfield><subfield code="t">Effects of the nitrification inhibitor nitrapyrin and mulch on N</subfield><subfield code="d">2020</subfield><subfield code="d">EGM</subfield><subfield code="g">[Cham]</subfield><subfield code="w">(DE-627)ELV005292379</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:7</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:267-271</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.eurger.2015.11.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GGO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.12</subfield><subfield code="j">Umweltchemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.13</subfield><subfield code="j">Umwelttoxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.13</subfield><subfield code="j">Medizinische Ökologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">7</subfield><subfield code="j">2016</subfield><subfield code="e">3</subfield><subfield code="h">267-271</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.401717 |